Influenza A virus-IN-8

SKU HY-149034-Get quote Category Tags , ,

Products Details

Product Description

– Influenza A virus-IN-8 (S5) is a macrocyclic peptide with no cytotoxic. Influenza A virus-IN-8 is also a potent Influenza A Virus (IAV) inhibitor (with sufficient protease stability) with IC50s of 6.7 and 6.6 nM for H1 and H5 variants, respectively. Influenza A virus-IN-8 shows good affinitiescan to H1 variants, binds to a conserved region in the HA stem with a Kd of 1.0 nM[1].

Web ID

– HY-149034

Shipping

– Room temperature

Applications

– COVID-19-anti-virus

Molecular Formula

– C104H142N28O24S

References

– [1]Pascha MN, et al. Inhibition of H1 and H5 Influenza A Virus Entry by Diverse Macrocyclic Peptides Targeting the Hemagglutinin Stem Region. ACS Chem Biol. 2022 Aug 4.

Molecular Weight

– 2200.48

SMILES

– O=C(NCC(N)=O)[C@H](CSCC1=O)NC([C@H](C(C)C)NC([C@H](CC2=CNC3=C2C=CC=C3)NC([C@H](CC4=CN=CN4)NC([C@@]([C@@H](C)O)([H])NC([C@H](C)NC([C@H](CC(C)C)NC([C@@]([C@H](O)C)([H])NC(CNC([C@H](CC5=CN=CN5)NC([C@H](CC(O)=O)NC([C@H](CC6=CNC7=C6C=CC=C7)NC([C@H](CCCNC(N)=N)NC([C@H](CC8=CC=CC=C8)NC([C@H](CC(C)C)NC([C@H](C(C)C)NC([C@@H](N1[H])CC9=CC=C(O)C=C9)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

Clinical Information

– No Development Reported

Research Area

– Infection

Solubility

– 10 mM in DMSO

Target

– Influenza Virus

Pathway

– Anti-infection

Product type

– Peptides

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=